Associate Professor Chiara Melloni
Quintiles Transnational Corp., Durham (United States of America)
Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and active cancer: insights from the ARISTOTLE trial
Event: ESC Congress 2016
Topic: Atrial fibrillation (AF)
Session: New trends in antithrombotic therapy for atrial fibrillation
ESC 365 is supported by
